DO US MANAGED CARE ORGANIZATIONS RESTRICT COVERAGE MORE THAN THE FOOD AND DRUG ADMINISTRATION LABEL?

被引：0
|
作者：
Da Conceicao, R. [1 ]
Narvekar, P. [1 ]
Okorozo, P. [2 ]
机构：
[1] Avalere Hlth, New York, NY USA
[2] Avalere Hlth, Buffalo, NY USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HPR116
引用
收藏
页码：S214 / S215
页数：2
相关论文
共 50 条
  • [41] Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database
    Kaniz Afroz Tanni
    Cong Bang Truong
    Sura Almahasis
    Jingjing Qian
    BioDrugs, 2021, 35 : 239 - 254
  • [42] Real-World Evidence (RWE) Studies Supported Hematologic Oncology United States Food and Drug Administration (US FDA) Approval: What Do They Look like?
    Yue, Binglin
    Greenbaum, Adam
    Sun, Shaohui
    Zhu, Enda
    Weng, Shicheng
    Du, Chenmu
    Zhang, Xiaojuan
    Liao, Shanmei
    BLOOD, 2022, 140 : 13208 - 13209
  • [43] Comment on: "Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database"
    Putzke, Joerg
    Haughie, Scott
    Zou, Kelly H.
    Ranganna, Gopinath M.
    BIODRUGS, 2021, 35 (03) : 373 - 374
  • [44] Coming changes to mammography standards With its proposed amendments to update mammography rules, the US Food and Drug Administration hopes to empower patients and health care providers
    Printz, Carrie
    CANCER, 2019, 125 (18) : 3097 - 3099
  • [45] Conflicting verdicts on peanut oral immunotherapy from the Institute for Clinical and Economic Review and US Food and Drug Administration Advisory Committee: Where do we go from here?
    Eiwegger, Thomas
    Anagnostou, Katherine
    Arasi, Stefania
    Begin, Philippe
    Ben-Shoshan, Moshe
    Beyer, Kirsten
    Blumchen, Katharina
    Brough, Helen
    Caubet, Jean-Christoph
    Chan, Edmond S.
    Chen, Meng
    Chinthrajah, Sharon
    Davis, Carla M.
    Roches, Anne Des
    Du Toit, George
    Elizur, Arnon
    Galli, Stephen J.
    Haland, Geir
    Hoffmann-Sommergruber, Karin
    Kim, Harold
    Leung, Donald Y. M.
    Long, Andrew
    Muraro, Antonella
    Nurmatov, Ulugbek B.
    Pajno, Giovanni B.
    Sampath, Vanitha
    Saxena, Jamie
    Sindher, Sayantani
    Upton, Julia
    Worm, Margitta
    Nadeau, Kari C.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (04) : 1153 - 1156
  • [46] Cost-utility of cognitive behavioral therapy versus US Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial
    Luciano, Juan V.
    D'Amico, Francesco
    Cerda-Lafont, Marta
    Penarrubia-Maria, Maria T.
    Knapp, Martin
    Cuesta-Vargas, Antonio I.
    Serrano-Blanco, Antoni
    Garcia-Campayo, Javier
    ARTHRITIS RESEARCH & THERAPY, 2014, 16 (05)
  • [47] Author’s Reply to Joerg Putzke et al. Comment on: “Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database”
    Jingjing Qian
    Cong Bang Truong
    Kaniz Afroz Tanni
    BioDrugs, 2021, 35 : 375 - 377
  • [48] Author's Reply to Joerg Putzke et al. Comment on: "Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database"
    Qian, Jingjing
    Truong, Cong Bang
    Tanni, Kaniz Afroz
    BIODRUGS, 2021, 35 (03) : 375 - 377
  • [49] Mature artificial intelligence- and machine learning-enabled medical tools impacting vascular surgical care: A scoping review of late-stage, US Food and Drug Administration-approved or cleared technologies relevant to vascular surgeons
    Stonko, David P.
    Hicks, Caitlin W.
    SEMINARS IN VASCULAR SURGERY, 2023, 36 (03) : 460 - 470
  • [50] Change in Use of Gadolinium-Enhanced Magnetic Resonance Studies in Kidney Disease Patients After US Food and Drug Administration Warnings: A Cross-sectional Study of Veterans Affairs Health Care System Data From 2005-2008
    Kim, Kyung-Ho
    Fonda, Jennifer R.
    Lawler, Elizabeth V.
    Gagnon, David
    Kaufman, James S.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 56 (03) : 458 - 467
12345